[[File:Proteopathy_Abeta_deposits_in_Alzheimer_disease.jpg|thumb]]染色的阿尔茨海默病患者[[大脑皮质|大脑皮质]]切片的[[显微照相|显微照相]]，该蛋白片段在[[老年斑|老年斑]]和脑淀粉样血管病中积聚。10倍显微镜物镜。]]
在[[医学|医学]]上，'''蛋白质构象病'''（{{lang-en|'''proteopathy'''}}）是指某些[[蛋白质|蛋白质]]的结构变得异常，从而破坏身体[[细胞|细胞]]、[[组织|组织]]和[[器官|器官]]的功能的[[疾病|疾病]]。<ref name="Walker1">{{cite journal |vauthors=Walker LC, LeVine III H | title = The cerebral proteopathies | journal = Neurobiol Aging | volume = 21 | pages = 559–561 | year = 2000 | pmid = 10924770 | doi = 10.1016/S0197-4580(00)00160-3 | issue = 4}}</ref><ref name="Walker2">{{cite journal |vauthors=Walker LC, LeVine III H | title = The cerebral proteopathies: Neurodegenerative disorders of protein conformation and assembly | journal = Mol Neurobiol | volume = 21 | pages = 83–95 | year = 2000 | pmid = 11327151 | doi = 10.1385/MN:21:1-2:083 | issue = 1–2}}</ref>  通常这些蛋白质无法折叠成它们本来的正常结构；当处于这种错误折叠的状态时，它们在某种程度上可能变得有毒（毒性作用增强）或失去它们正常的功能。<ref name="Luheshi">{{cite journal |vauthors=Luheshi M, Crowther DC, Dobson CM | title = Protein misfolding and disease: from the test tube to the organism | journal = Current Opinion in Chemical Biology | volume = 12 | pages = 25–31 | year = 2008 | pmid = 18295611 | issue = 1 | doi = 10.1016/j.cbpa.2008.02.011}}</ref>  蛋白质构象病（又称'''蛋白质错误折叠病'''）包括如[[克雅二氏病|克雅二氏病]]和其他[[朊毒体|朊毒体]]疾病、[[阿尔茨海默病|阿尔茨海默病]]、[[帕金森病|帕金森病]]、[[淀粉样变|淀粉样变]]和一系列其他的疾病。<ref name="Walker2" /><ref name="Chiti">{{cite journal |vauthors=Chiti F, Dobson CM | title = Protein misfolding, functional amyloid, and human disease | journal = Annu Rev Biochem | volume = 75 | issue = 1 | pages = 333–366 | year = 2006 | pmid = 16756495 | doi = 10.1146/annurev.biochem.75.101304.123901}}</ref><ref name="Carrell">{{cite journal |vauthors=Carrell RW, Lomas DA | title = Conformational disease | journal = Lancet | volume = 350 | pages = 134–138 | year = 1997 | pmid = 9228977 | doi = 10.1016/S0140-6736(97)02073-4 | issue = 9071}}</ref><ref name = "Westermark">{{cite journal  |vauthors=Westermark P, etal | title = A primer of amyloid nomenclature | journal = Amyloid | volume = 14 | pages = 179–183 | year = 2007 | pmid = 17701465 | doi = 10.1080/13506120701460923 | issue = 3}}</ref><ref>{{cite journal|last1=Westermark|first1=GT et al.|title=Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission|journal=Cold Spring Harb Perspect Med|date=2017|doi=10.1101/cshperspect.a024323|pmid=28108533|volume=8|page=a024323}}</ref><ref name="Prusiner 2013">{{cite journal|last1=Prusiner|first1=SB|title=Biology and genetics of prions causing neurodegeneration|journal=Annu Rev Genet|volume=47|pages=601–623|date=2013|doi=10.1146/annurev-genet-110711-155524|pmid=24274755|pmc=4010318}}</ref>

蛋白质构象病的概念可以追溯到19世纪中叶。1854年，[[鲁道夫·菲尔绍|鲁道夫·菲尔绍]]提出使用[[淀粉样蛋白|淀粉样蛋白]]（“淀粉样”）这个术语来描述大脑中的一种叫做淀粉样小体的物质。这种物质表现出类似于[[纤维素|纤维素]]的化学反应。1859年，尼古拉斯·弗里德里希和[[凯库勒|凯库勒]]证明了“淀粉样蛋白”实际上富含大量蛋白质，而不是纤维素组成的。<ref name="Sipe">{{cite journal |vauthors=Sipe JD, Cohen AS | title = Review: History of the amyloid fibril | journal = J Struct Biol | volume = 130 | pages = 88–98 | year = 2000 | pmid = 10940217 | doi = 10.1006/jsbi.2000.4221 | issue = 2–3}}</ref>  随后的研究表明，许多不同的蛋白质都可以形成淀粉样蛋白，并且所有的淀粉样蛋白质在经[[刚果红|刚果红]]染色后的交叉[[偏振光|偏振光]]中都有共同的[[双折射|双折射]]；当用[[电子显微镜|电子显微镜]]观察时会出现一个纤维状的[[亚显微结构|亚显微结构]]。<ref name="Sipe"/> 然而，一些蛋白质病变没有双折射现象，它们包含很少甚至没有像阿尔茨海默病患病者脑中弥漫性沉积的Aβ蛋白那样典型的淀粉样纤维。<ref name="Wisniewski">{{cite journal | doi = 10.1097/00005072-199807000-00004 |vauthors=Wisniewski HM, Sadowski M, Jakubowska-Sadowska K, Tarnawski M, Wegiel J | title = Diffuse, lake-like amyloid-beta deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease | journal = J Neuropath Exp Neurol | volume = 57 | pages = 674–683 | year = 1998 | pmid = 9690671 | issue = 7}}</ref>  此外有证据表明，小的非纤维状蛋白质聚集体（[[低聚物|低聚物]]）对受影响器官的细胞来说是有毒的，而纤维状淀粉样蛋白相对而言是良性的。<ref name="Glabe">{{cite journal | author = Glabe CG | title = Common mechanisms of amyloid oligomer pathogenesis in degenerative disease | journal = Neurobiol Aging | volume = 27 | pages = 570–575 | year = 2006 | pmid = 16481071 | issue = 4 | doi = 10.1016/j.neurobiolaging.2005.04.017}}</ref><ref name="Gadad">{{cite journal |vauthors=Gadad BS, Britton GB, Rao KS | title = Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide | journal = Journal of Alzheimer's disease : JAD | volume = 24 Suppl 2 | pages = 223–232 | year = 2011 | pmid = 21460436 | doi = 10.3233/JAD-2011-110182}}</ref>

==病理生理学==
大多数情况下，如果不是所有的蛋白质病变，三维折叠（构象）的变化都会增加特定蛋白质与其自身结合的趋势。<ref name="Carrell"/>  在这种聚集形式下，蛋白质对清除有抗性，并且可能干扰受影响器官的正常功能。在通常情况下，蛋白质错误折叠会导致其丧失常规功能。例如，[[囊肿性纤维化|囊肿性纤维化]]是由有缺陷的囊肿性纤维化跨膜传导调节因子（CFTR）蛋白引起的。<ref name="Luheshi"/>  而在肌萎缩侧索硬化/额颞叶变性（FTLD）中，某些基因调节蛋白不适当地聚集在细胞质中，无法在核内执行其正常任务。<ref name="ItoSuzuki">{{cite journal |vauthors=Ito D, Suzuki N | title = Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS | journal = Neurology | volume = 77| year = 2011 | pmid = 21956718 | doi = 10.1212/WNL.0b013e3182343365 | issue=17 | pmc=3198978 | pages=1636–43}}</ref><ref name="Wolozin 2015">{{cite journal|last1=Wolozin|first1=B|authorlink=Benjamin Wolozin |last2=Apicco|first2=D|title=RNA binding proteins and the genesis of neurodegenerative diseases|journal=Adv Exp Med Biol|volume=822|pages=11–15|date=2015|doi=10.1007/978-3-319-08927-0_3}}</ref>  蛋白质有一个称为[[多肽|多肽]]骨架的共同的结构特征，所以所有蛋白质在某些情况下都可能发生错误折叠。<ref name="Dobson">{{cite journal | author = Dobson CM | title = Protein misfolding, evolution and disease | journal = TIBS | volume = 24 | pages = 329–332 | year = 1999 | pmid = 10470028 | issue = 9 | doi=10.1016/S0968-0004(99)01445-0}}</ref>  然而，只有少量蛋白质错误折叠与蛋白质构象病有关。这可能是由于蛋白质自身脆弱的结构特质。例如，通常作为[[单体|单体]]（即单一的、未结合的蛋白质分子）展开或相对不稳定的蛋白质更容易错误折叠导致构象异常。<ref name="Carrell"/><ref name="Dobson"/><ref name="Jucker and Walker 2013">{{cite journal|last1=Jucker|first1=M|last2=Walker|first2=LC|title=Self-propagation of pathogenic protein aggregates in neurodegenerative diseases|journal=Nature|volume=501|pages=45–51| date=2013|doi=10.1038/nature12481}}</ref>  几乎在所有情况下，致病分子构型都涉及蛋白质的[[β折叠|β折叠]]二级结构的增加。<ref name="Carrell"/><ref name="Dobson"/><ref name="Selkoe">{{cite journal | author = Selkoe DJ | title = Folding proteins in fatal ways | journal = Nature | volume = 426 | pages = 900–904 | year = 2003 | doi = 10.1038/nature02264 | pmid = 14685251 | issue = 6968}}</ref><ref name="Eisenberg and Jucker 2012">{{cite journal|last1=Eisenberg|first1=D|last2=Jucker|first2=M|title=The amyloid state of proteins in human diseases|journal=Cell|date=2012|volume=148|pages=1188–1203|doi=10.1016/j.cell.2012.02.022}}</ref>  一些蛋白质构象病中的异常蛋白已被证明可折叠成多个三维形状；这些变体蛋白质结构由其不同的致病性、生物化学性质和构象特性来定义。<ref name="Walker LC 2016">{{cite journal|last1=Walker|first1=LC|title=Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases|journal=Annu Rev Genet|date=2016|volume=50|pages=329–346|doi=10.1146/annurev-genet-120215-034943}}</ref>  目前已经对被称为蛋白质菌株的朊毒体疾病进行了相当深入的研究。<ref name="Collinge">{{cite journal |vauthors=Collinge J, Clarke AR | title = A general model of prion strains and their pathogenicity | journal = Science | volume = 318 | pages = 930–936 | year = 2007 | pmid = 17991853 | issue = 5852 | doi = 10.1126/science.1138718}}</ref><ref name="Colby">{{cite journal |vauthors=Colby DW, Prusiner SB | title = De novo generation of prion strains | journal = Nature Reviews Microbiology | volume =  9| year = 2011 | pmid = 21947062 | doi = 10.1038/nrmicro2650 | issue = 11 | pages = 771–7}}</ref>

==参见==
* [[淀粉样变|淀粉样变]]

==参考资料==
{{reflist|35em}}

[[Category:蛋白质折叠|Category:蛋白质折叠]]
[[Category:神經系統疾病|Category:神經系統疾病]]
[[Category:病理学|Category:病理学]]